Disclosed are compounds of formula I: ##STR00001## wherein X is a
carbonyl, sulfonyl, methylene, or methylene substituted with optionally
substituted phenyl; Z is nitrogen or CH; Ar.sub.1 and Ar.sub.2
independently represent aryl groups; and Y is hydrogen; or Y and R.sub.1
or R.sub.2 together represent CH.sub.2; CH.sub.2CH.sub.2; CH.sub.2O;
CH.sub.2S forming a five or six membered ring and such ring may be
optionally substituted with loweralkyl or phenyl; or the pharmaceutically
acceptable salts thereof, useful in the treatment of neoplastic diseases,
and bacterial or fungal infections, and in preventing or decreasing the
production of abnormally phosphorylated paired helical filament (PHF)
epitopes associated with Alzheimer's Disease and, therefore, useful for
treating Alzheimer's Disease.